CDH1 and cancer: The pro‐EMT effects of NETs observed in our study, including increased expression of mesenchymal markers (Vimentin and N‐cadherin) and decreased expression of the epithelial marker E‐cadherin, along with enhanced invasive and migratory capabilities, are in line with emerging evidence implicating NETs in cancer progression [18, 19].